|
|
|
Volumn 96, Issue 2, 2000, Pages 48-56
|
|
Scientific and legal issues in fenfluramine/dexfenfluramine litigation.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIOBESITY AGENT;
DEXFENFLURAMINE;
FENFLURAMINE;
SEROTONIN AGONIST;
SEROTONIN UPTAKE INHIBITOR;
CHEMICALLY INDUCED DISORDER;
HUMAN;
MEDICOLEGAL ASPECT;
PULMONARY HYPERTENSION;
REVIEW;
RISK ASSESSMENT;
SCIENCE;
TOXICITY AND INTOXICATION;
VALVULAR HEART DISEASE;
WEIGHT REDUCTION;
ANTI-OBESITY AGENTS;
DEXFENFLURAMINE;
FENFLURAMINE;
HEART VALVE DISEASES;
HUMANS;
HYPERTENSION, PULMONARY;
LEGISLATION, MEDICAL;
NEUROTOXICITY SYNDROMES;
RISK ASSESSMENT;
SCIENCE;
SEROTONIN AGONISTS;
SEROTONIN UPTAKE INHIBITORS;
WEIGHT LOSS;
|
|
EID: 0034132284
PISSN: 00404470
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (8)
|
|
References (85)
|